Equity Overview
Price & Market Data
Price: $54.42
Daily Change: +$2.60 / 4.78%
Daily Range: $52.01 - $59.98
Market Cap: $4,039,795,994
Daily Volume: 257,081
Performance Metrics
1 Week: 36.53%
1 Month: 516.3%
3 Months: 262.8%
6 Months: 262.8%
1 Year: 262.8%
YTD: -1936000.00%
Company Details
Employees: 29
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.